GE HealthCare surges after Q2 earnings beat while Humana retreats despite profit growth amid medical cost concerns.
GE HealthCare Technologies (GEHC) climbed to the top of the S&P 500 Wednesday, breaking out of a recent trading range after reporting better-than-expected Q2 earnings. The company’s return to profit growth lifted shares above prior resistance levels following a Q1 decline.
Humana (HUM) lagged despite also posting stronger-than-anticipated Q2 results, extending losses from recent highs and testing key support. Concerns over medical cost trends weighed on the stock, echoing broader sector volatility after UnitedHealth’s (UNH) post-earnings pullback earlier this week.